X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs MYLAN (US) - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN LTD   MYLAN
EQUITY SHARE DATA
    LUPIN LTD
Mar-17
MYLAN
Dec-14
LUPIN LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,7504,066-   
Low Rs1,3842,865-   
Sales per share (Unadj.) Rs387.41,391.9-  
Earnings per share (Unadj.) Rs56.6167.7-  
Cash flow per share (Unadj.) Rs76.8269.9-  
Dividends per share (Unadj.) Rs7.500-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs298.9691.9-  
Shares outstanding (eoy) m451.58378.37-   
Bonus/Rights/Conversions ESOPSOI-  
Price / Sales ratio x4.02.5 162.4%   
Avg P/E ratio x27.720.7 133.9%  
P/CF ratio (eoy) x20.412.8 158.8%  
Price / Book Value ratio x5.25.0 104.7%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m707,5131,311,270 54.0%   
No. of employees `00016.825.0 67.2%   
Total wages/salary Rs m28,4950-   
Avg. sales/employee Rs Th10,418.321,066.3 49.5%   
Avg. wages/employee Rs Th1,697.00-   
Avg. net profit/employee Rs Th1,523.02,537.8 60.0%   
INCOME DATA
Net Sales Rs m174,943526,658 33.2%  
Other income Rs m1,065-3,070 -34.7%   
Total revenues Rs m176,008523,589 33.6%   
Gross profit Rs m44,931130,982 34.3%  
Depreciation Rs m9,12238,681 23.6%   
Interest Rs m1,52522,717 6.7%   
Profit before tax Rs m35,34966,515 53.1%   
Minority Interest Rs m-72-273 26.3%   
Prior Period Items Rs m830-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,7852,797 349.8%   
Profit after tax Rs m25,57563,445 40.3%  
Gross profit margin %25.724.9 103.3%  
Effective tax rate %27.74.2 658.3%   
Net profit margin %14.612.0 121.4%  
BALANCE SHEET DATA
Current assets Rs m119,542463,002 25.8%   
Current liabilities Rs m61,206361,975 16.9%   
Net working cap to sales %33.319.2 173.8%  
Current ratio x2.01.3 152.7%  
Inventory Days Days7678 97.4%  
Debtors Days Days90107 83.8%  
Net fixed assets Rs m131,660121,841 108.1%   
Share capital Rs m90318,624 4.8%   
"Free" reserves Rs m134,0730-   
Net worth Rs m134,976261,801 51.6%   
Long term debt Rs m56,478391,105 14.4%   
Total assets Rs m266,0731,054,511 25.2%  
Interest coverage x24.23.9 615.5%   
Debt to equity ratio x0.41.5 28.0%  
Sales to assets ratio x0.70.5 131.6%   
Return on assets %10.28.2 124.7%  
Return on equity %18.924.2 78.2%  
Return on capital %19.313.6 141.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m60,3780-   
CASH FLOW
From Operations Rs m41,14869,230 59.4%  
From Investments Rs m-25,287-54,596 46.3%  
From Financial Activity Rs m4,332-18,242 -23.7%  
Net Cashflow Rs m20,193-3,609 -559.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 68.22 Rs / USD

Compare LUPIN LTD With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare LUPIN LTD With: ELDER PHARMA  AUROBINDO PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  SANOFI INDIA  



Today's Market

Sensex Opens Higher; Consumer Durables & Bank Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.8% while the Hang Seng is down 0.4%.

Related Views On News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Jun 21, 2018 10:05 AM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS